| # | Drug | Count |
|---|---|---|
| 0 | DROSPIRENONE AND ETHINYL ESTRADIOL | 243 |
| 1 | BEVACIZUMAB | 84 |
| 2 | IBUPROFEN | 63 |
| 3 | ASPIRIN | 58 |
| 4 | ASPIRIN 325 MG | 54 |
| 5 | ASPIRIN 81 MG | 54 |
| 6 | CISPLATIN | 53 |
| 7 | PREDNISONE | 46 |
| 8 | CARBOPLATIN | 45 |
| 9 | IBUPFROFEN | 44 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BENZOCAINE, BUTAMBEN, AND TETRACAINE HYDROCHLORIDE | 1 | 0.0303 |
| 1 | COUMARIN | 4 | 0.0244 |
| 2 | DEXBROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0123 |
| 3 | PENTOBARBITAL SODIUM | 1 | 0.0108 |
| 4 | CROVALIMAB | 1 | 0.0083 |
| 5 | DIETHYLPROPION HYDROCHLORIDE | 1 | 0.0078 |
| 6 | ETHIODIZED OIL | 9 | 0.0069 |
| 7 | CLINDAMYCIN PHOSPHATE AND TRETINOIN | 1 | 0.0065 |
| 8 | DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE CALCIUM AND LEVOMEFOLATE CALCIUM | 11 | 0.0061 |
| 9 | DROSPIRENONE AND ETHINYL ESTRADIOL | 243 | 0.0055 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 150 |
| 1 | Corticosteroid [EPC] | 130 |
| 2 | Platinum-based Drug [EPC] | 129 |
| 3 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 99 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 66 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 63 |
| 6 | Benzodiazepine [EPC] | 61 |
| 7 | Factor Xa Inhibitor [EPC] | 56 |
| 8 | Microtubule Inhibitor [EPC] | 47 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 45 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 1 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 2 | Thrombopoietin Receptor Agonist [EPC] | 33 | 0.0022 |
| 3 | Anti-coagulant [EPC] | 8 | 0.0021 |
| 4 | Antihypoglycemic Agent [EPC] | 9 | 0.0021 |
| 5 | Osmotic Diuretic [EPC] | 7 | 0.0013 |
| 6 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 7 | Adrenal Steroid Synthesis Inhibitor [EPC] | 1 | 0.0010 |
| 8 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 9 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |